Showing results (71-80 of 211) with videos related to
Sort By:
Pageof 22
Expert Opinion on Drug Safety|December 19, 2003
Can dual blockade of the renin-angiotensin system reduce progression of kidney disease beyond monotherapy?Ursula C Brewster, Mark A PerazellaJournal of the American Society of Nephrology : JASN|July 1, 2018
Nephrotoxicity of Cancer Immunotherapies: Past, Present and FutureMark A Perazella, Anushree C ShiraliSeminars in Nephrology|December 15, 2010
Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapyMark A Perazella, Gilbert W MoeckelThe American Journal of the Medical Sciences|December 9, 2010
Imaging patients with kidney disease: how do we approach contrast-related toxicity?Mark A Perazella, Robert F ReillyClinical Journal of the American Society of Nephrology : CJASN|November 19, 2011
Traditional urinary biomarkers in the assessment of hospital-acquired AKIMark A Perazella, Steven G CocaKidney International Reports|January 1, 2019
Pink Urine Syndrome: A Combination of Insulin Resistance and PropofolBryan M Tucker, Mark A PerazellaAdvances in Kidney Disease and Health|September 14, 2025
The Tubulointerstitium in Health and Disease: More Than What Meets the EyeMark A Perazella, Pranav S GarimellaNature Reviews. Nephrology|June 3, 2010
Drug-induced acute interstitial nephritisMark A Perazella, Glen S MarkowitzAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 20, 2004
Acute interstitial nephritis associated with atazanavir, a new protease inhibitorUrsula C Brewster, Mark A PerazellaFrontiers in Medicine|August 29, 2022
The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicityEmily M Moss, Mark A PerazellaPageof 22